Amlotyle B Tablet combines Amlodipine 2.5 mg, a calcium channel blocker, and Bisoprolol 5 mg, a beta-blocker, for the management of hypertension and cardiovascular risk reduction. The combination works synergistically to relax blood vessels, lower heart rate, and reduce blood pressure, providing comprehensive cardiovascular protection.
Belonging to the cardiology segment, this combination is widely prescribed for patients with essential hypertension, angina, and other heart-related conditions. Its dual-action approach ensures enhanced efficacy and better patient adherence.
The combination helps in preventing complications such as stroke, myocardial infarction, and heart failure, making it a critical part of long-term hypertension management.
For PCD pharma franchise partners, distributors, exporters, and third-party manufacturing clients, Amlotyle B Tablet offers a profitable B2B opportunity. Its inclusion in cardiology portfolios ensures stable demand across hospitals, clinics, and retail pharmacies in India.